|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 213/72 | |
| A61K 45/06 | |||
| A61K 31/444 | |||
| A61P 3/04 | |||
| C07D 401/12 |
| (11) | Number of the document | 2625172 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11770622.6 |
| Date of filing the European patent application | 2011-10-05 | |
| (97) | Date of publication of the European application | 2013-08-14 |
| (45) | Date of publication and mention of the grant of the patent | 2016-12-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/054841 |
| Date | 2011-10-05 |
| (87) | Number | WO 2012/047948 |
| Date | 2012-04-12 |
| (30) | Number | Date | Country code |
| 390888 P | 2010-10-07 | US |
| (72) |
SUTTON, Paul, Allen, US
GIRGIS, Michael, J., US
LIANG, Jessica, US
PRASHAD, Mahavir, US
VILLHAUER, Edwin, Bernard, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | NEW CRYSTALLINE FORMS OF THE SODIUM SALT OF (4- {4- [5- ( 6 - TRIFLUOROMETHYL - PYRIDIN- 3 - YLAMINO ) - PYRIDIN- 2 -YL]-PHENYL} - CYCLOHEXYL) -ACETIC ACID |
| NEW CRYSTALLINE FORMS OF THE SODIUM SALT OF (4- {4- [5- ( 6 - TRIFLUOROMETHYL - PYRIDIN- 3 - YLAMINO ) - PYRIDIN- 2 -YL]-PHENYL} - CYCLOHEXYL) -ACETIC ACID |